Cutaneous ulcer as the initial manifestation of rheumatoid arthritis. Case report
DOI:
https://doi.org/10.5281/zenodo.10998940Keywords:
Extra-Articular Manifestations, Skin Ulcer, Rheumatoid ArthritisAbstract
Background: 20-40% of patients with rheumatoid arthritis (RA) present an extra-articular manifestation (EAM) and 1-20% a severe EAM, with an increased risk of death (> 2 times). The associated lesions are: 27.5% rheumatoid nodules, and 0.5% neutrophilic dermatitis, palisaded neutrophilic granulomatous dermatitis, and/or cutaneous vasculitis.
Clinical case: 52-year-old woman who suddenly presented with a painful skin ulcer on the dorsum of the left foot with violaceous, well-defined, raised edges and granulation tissue with fibrinopurulent membranes, with an edematous halo, and subsequent crusting and perilesional hyperpigmentation. The lesion did not show improvement despite debridement and antibiotics. Biopsy with abundant neutrophils in the dermis and vasculitis was reported. Paraclinical testing showed: C-reactive protein: 32.5 mg/dL, erythrocyte sedimentation rate: 59 mm/h, and rheumatoid factor (RF): 2460 U/mL, in addition to antinuclear antibodies (1:640), negative anti-DNA, and anti-citrullinated protein/peptide antibodies (ACPA/anti-CCP) positive (221.70 U/mL), confirming the diagnosis of RA.
Conclusions: Rheumatoid vasculitis is the most serious EAM of RA, with more than 40% of patients dying 5 years after clinical onset. It is a rare complication and more common in men with longstanding RA. We highlight the importance of suspecting autoimmune pathology, especially RA, in the presence of spontaneous skin ulcers, without an infectious component and with alterations in the basic laboratory tests.
Downloads
References
Smolen J, Aletaha D, Burmester G. Rheumatoid arthritis. Nature Reviews Disease Primers. 2018;4(1). doi: 10.1038/nrdp.2018.2.
Sánchez-Cárdenas G, Contreras-Yáñez I, Guaracha-Basáñez G, et al. Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: A cross-sectional study in a cohort of patients with recent-onset disease. Clinical Rheumatology. 2021. doi: 10.1007/s10067-021-05664-0.
Engin B, Sevim A, Cesur SK, et al. Eruptions in life-threatening rheumatologic diseases. Clinics in Dermatology. 2020;38(1):86-93. doi: 10.1016/j.clindermatol.2019.10.016.
Giles JT. Extra-articular manifestations and comorbidity in rheumatoid arthritis: Potential impact of pre–rheumatoid arthritis prevention. Clinical Therapeutics. 2019;41(7):1246-55. doi: 10.1016/j.clinthera.2019.04.018.
Marcucci E, Bartoloni E, Alunno A, et al. Extra-articular rheumatoid arthritis. Reumatismo. 2018;70(4):212-24. doi: 10.4081/reumatismo.2018.1106.
Chimenti MS, Di Stefani A, Conigliaro P, et al. Histopathology of the skin in rheumatic diseases. Reumatismo. 2018;187-98. doi: 10.4081/reumatismo.2018.1049.
Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4):880. doi: 10.3390/cells9040880.
Mazzoni D, Kubler P, Muir J. Recognising skin manifestations of rheumatological disease. Australian Journal of General Practice. 2021;50(12):873-8. doi: 10.31128/ajgp-02-21-5863.
Gerel M. Cutaneous manifestations of rheumatoid arthritis. Journal of the Dermatology Nurses’ Association. 2020;12(5). doi: 10.1097/jdn.0000000000000568.
Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Primary Care: Clinics in Office Practice. 2018;45(2):237-55. doi: 10.1016/j.pop.2018.02.010.
Sood A, Gonzalez D, Sonkar J, et al. Non-healing leg ulcers in a patient with rheumatoid arthritis. The American Journal of Medicine. 2021;134(10). doi: 10.1016/j.amjmed.2021.03.049.
Alves F, Gonçalo M. Suspected inflammatory rheumatic diseases in patients presenting with skin rashes. Best Practice & Research Clinical Rheumatology. 2019;33(4):101440. doi: 10.1016/j.berh.2019.101440.
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis. JAMA. 2018;320(13):1360. doi: 10.1001/jama.2018.13103.
Figus FA, Piga M, Azzolin I, et al. Rheumatoid arthritis: Extra-articular manifestations and Comorbidities. Autoimmunity Reviews. 2021;20(4):102776. doi: 10.1016/j.autrev.2021.102776.
Sankineni P, Meghana B. Skin in rheumatoid arthritis and seronegative arthritis. Clinical Dermatology Review. 2019;3(1):23. doi: 10.4103/cdr.cdr_47_18.
Pertsinidou E, Manivel VA, Westerlind H, et al. Rheumatoid arthritis autoantibodies and their association with age and sex. Clinical and Experimental Rheumatology. 2021;39(4):879-82. doi: 10.55563/clinexprheumatol/4bcmdb.
Lora V, Cerroni L, Cota C. Skin manifestations of rheumatoid arthritis. Italian Journal of Dermatology and Venereology. 2018;153(2). doi: 10.23736/s0392-0488.18.05872-8.
Lokineni S, Amr M, Boppana LKT, et al. Rheumatoid Vasculitis as an Initial Presentation of Rheumatoid Arthritis. Eur J Case Rep Intern Med. 2021;8(4):002561. doi: 10.12890/2021_002561.
Anwar MM, Tariq EF, Khan U, et al. Rheumatoid vasculitis: Is it always a late manifestation of rheumatoid arthritis? Cureus. 2019; doi: 10.7759/cureus.5790.
Olivé A, Riveros A, Juárez P, et al. Vasculitis reumatoide: Estudio de 41 Casos. Medicina Clínica. 2020;155(3):126-9. doi: 10.1016/j.medcli.2020.01.024.
Bastian H, Ziegeler K, Hermann KG, et al. Rheumatoide arthritis – mimics. Zeitschrift Für Rheumatologie. 2018;78(1):6-13. doi: 10.1007/s00393-018-0527-1.
Kridin K, Damiani G, Cohen AD. Rheumatoid arthritis and pyoderma gangrenosum: A population-based case-control study. Clinical Rheumatology. 2020;40(2):521-8. doi: 10.1007/s10067-020-05253-7.
Maverakis E, Marzano AV, Le ST, et al. Pyoderma gangrenosum. Nature Reviews Disease Primers. 2020;6(1). doi: 10.1038/s41572-020-0213-x.
Abdelkader HA, Abdel-Galeil Y, Elbendary A, et al. Multiple skin ulcers in a rheumatoid arthritis patient: Answer. The American Journal of Dermatopathology. 2020;42(2):146-7. doi: 10.1097/dad.0000000000001326.
Abdelkader HA, Abdel-Galeil Y, Elbendary A, et al. Multiple skin ulcers in a rheumatoid arthritis patient: Challenge. The American Journal of Dermatopathology. 2020;42(2). doi: 10.1097/dad.0000000000001334.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Médica del Instituto Mexicano del Seguro Social

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.